Xconomy Boston

Augmenix Garners $4,700,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ac23d83-8ee1-42f2-b733-85259025217e&Preview=1
Date
7/23/2009
Company Name
Augmenix
Mailing Address
204 2nd Avenue Waltham, MA 02451
Company Description
Augmenix™, Inc. is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Augmenix, Inc.’s initial product will be the first synthetic tissue spacer designed and indicated to reduce radiation exposure of normal tissues adjacent to prostate cancers.
Website
http://www.augmenix.com/
Transaction Type
Venture Equity
Transaction Amount
$4,700,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Undisclosed